About Biogen

Biogen is a leading biotechnology company founded in 1978 that develops innovative medicines for people living with serious neurological, immunological, and rare diseases. The company applies deep understanding of human biology to advance first-in-class treatments that transform patient outcomes in areas where effective therapies remain scarce. For nearly five decades, Biogen has maintained its commitment to bold scientific exploration, creating medicines for hard-to-treat conditions including Alzheimer's disease, multiple sclerosis, spinal muscular atrophy, and lupus. Operating globally with therapies in over 80 countries, the company continues expanding its pipeline whilst supporting patients through dedicated access programmes.